Dr Natalie Staplin
Natalie Staplin
PhD
MRC PHRU Senior Statistician
Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Sciences. She joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics. Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease. She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.
Recent publications
-
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.
Journal article
Haynes R. et al, (2018), Circulation, 138, 1505 - 1514
-
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients with Chronic Kidney Disease: A Randomised Double-Blind Trial.
Journal article
Haynes R. et al, (2018), Circulation
-
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
Journal article
3C Study Collaborative Group None., (2018), Am j transplant, 18, 1424 - 1434
-
Declining comorbidity-adjusted mortality rates in English patients receiving maintenance renal replacement therapy.
Journal article
Herrington W. et al, (2018), Kidney international
-
Impact of chronic kidney disease on household income
Journal article
Morton RL. et al, (2017), Kidney international reports